Key Takeaways Ventas is benefiting from aging population trends and rising healthcare spending demand.VTR's OM&R portfolio saw 3.7% NOI growth, with 2-3% growth expected in 2026.Ventas holds $5.3B liquidity and improved leverage, supporting future growth and stability.Ventas, Inc.’s (VTR) diverse portfolio of healthcare real estate assets is well-poised to capitalize on rising healthcare spending and an aging population. Also, accretive investments in the research portfolio and a solid balance sheet bode we ...